Selected article for: "ace angiotensin and acute lung failure"
Author: Kuba, Keiji; Imai, Yumiko; Ohto-Nakanishi, Takayo; Penninger, Josef M.
Title: Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters
  • Cord-id: 5xcil8eb
  • Document date: 2010_7_3
    • ID: 5xcil8eb
    Snippet: Angiotensin-converting enzyme (ACE) 2 is a homolog to the carboxypeptidase ACE, which generates angiotensin II, the main active peptide of renin–angiotensin system (RAS). After the cloning of ACE2 in 2000, three major ACE2 functions have been described so far. First ACE2 has emerged as a potent negative regulator of the RAS counterbalancing the multiple functions of ACE. By targeting angiotensin II ACE2 exhibits a protective role in the cardiovascular system and many other organs. Second ACE2
    Document: Angiotensin-converting enzyme (ACE) 2 is a homolog to the carboxypeptidase ACE, which generates angiotensin II, the main active peptide of renin–angiotensin system (RAS). After the cloning of ACE2 in 2000, three major ACE2 functions have been described so far. First ACE2 has emerged as a potent negative regulator of the RAS counterbalancing the multiple functions of ACE. By targeting angiotensin II ACE2 exhibits a protective role in the cardiovascular system and many other organs. Second ACE2 was identified as an essential receptor for the SARS coronavirus that causes severe acute lung failure. Downregulation of ACE2 strongly contributes to the pathogenesis of severe lung failure. Third, both ACE2 and its homologue Collectrin can associate with amino acid transporters and play essential role in the absorption of amino acids in the kidney and gut. In this review, we will discuss the multiple biological functions of ACE2.

    Search related documents:
    Co phrase search for related documents
    • aberrant activation and active site: 1
    • aberrant activation and acute ards respiratory distress syndrome: 1
    • aberrant activation and acute lung injury: 1, 2, 3, 4
    • aberrant activation and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • aberrant activation and local hypoxia: 1
    • aberrant activation and local systemic: 1
    • aberrant activation and lung colon: 1
    • aberrant activation and lung disease: 1, 2, 3
    • aberrant activation and lung edema: 1, 2
    • aberrant activation and lung failure: 1, 2
    • aberrant activation and lung injury: 1, 2, 3, 4, 5, 6, 7
    • aberrant activation and lung injury model: 1
    • aberrant activation and lung repair: 1
    • aberrant activation and lung tissue: 1, 2, 3, 4
    • abnormal activation and acute ards respiratory distress syndrome: 1
    • abnormal activation and acute lung injury: 1
    • abnormal activation and acute respiratory syndrome: 1, 2, 3, 4
    • abnormal activation and lung disease: 1, 2, 3, 4, 5
    • abnormal activation and lung injury: 1